» Articles » PMID: 33386593

Impact of 2 Gy γ-irradiation on the Hallmark Characteristics of Human Bone Marrow-derived MSCs

Overview
Journal Int J Hematol
Specialty Hematology
Date 2021 Jan 2
PMID 33386593
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Two gray γ-irradiation is a widely employed basic module for total body irradiation (TBI) in allogeneic hematopoietic cell transplantation (HCT). The effects of γ-irradiation on hematopoietic and immune cells have been well investigated, but its effects on the bone marrow microenvironment (BMM) are unknown. Given the crucial contribution of mesenchymal/stromal stem cells (MSCs) in the BMM to hematopoiesis and osteogenesis, we investigated whether γ-irradiation affects the hallmark characteristics of human bone marrow-derived MSCs (BM-MSCs). Expansion of 2 Gy γ-irradiated BM-MSCs was delayed but eventually recovered. Colony formation and osteogenic, adipogenic, and chondrogenic differentiation capabilities of these cells were extensively suppressed. Irradiation of BM-MSCs did not affect the expansion of CD34 + hematopoietic stem and progenitor cells or production of CD11b + mature myeloid cells in co-cultures. However, it reduced production of CD19 + B-cells, as well as expression of CXCL12 and interleukin-7, which are essential for B-cell lymphopoiesis, in 2 Gy γ-irradiated BM-MSCs. Collectively, colony formation, osteogenic differentiation, and B-cell lymphopoiesis-supportive capabilities of γ-irradiated BM-MSCs were reduced. These effects may predispose survivors receiving HCT with TBI to defective bone formation and a perturbed humoral immune response.

Citing Articles

Cell-based and extracellular vesicle-based MSC therapies for acute radiation syndrome affecting organ systems.

Miura Y, Fujii S, Ichinohe T J Radiat Res. 2024; 65(Supplement_1):i80-i87.

PMID: 39679884 PMC: 11647929. DOI: 10.1093/jrr/rrae009.


Lenalidomide and pomalidomide modulate hematopoietic cell expansion and differentiation in the presence of MSC.

Fujii S, Miura Y Int J Hematol. 2024; 120(3):278-289.

PMID: 38995485 PMC: 11362235. DOI: 10.1007/s12185-024-03815-y.

References
1.
Thomas E, Clift R, Hersman J, Sanders J, Stewart P, Buckner C . Marrow transplantation for acute nonlymphoblastic leukemic in first remission using fractionated or single-dose irradiation. Int J Radiat Oncol Biol Phys. 1982; 8(5):817-21. DOI: 10.1016/0360-3016(82)90083-9. View

2.
Deeg H, Sullivan K, Buckner C, Storb R, Appelbaum F, Clift R . Marrow transplantation for acute nonlymphoblastic leukemia in first remission: toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiation. Bone Marrow Transplant. 1986; 1(2):151-7. View

3.
Storb R, Gyurkocza B, Storer B, Sorror M, Blume K, Niederwieser D . Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation. J Clin Oncol. 2013; 31(12):1530-8. PMC: 3625710. DOI: 10.1200/JCO.2012.45.0247. View

4.
Majhail N, Rizzo J . Surviving the cure: long term followup of hematopoietic cell transplant recipients. Bone Marrow Transplant. 2013; 48(9):1145-51. DOI: 10.1038/bmt.2012.258. View

5.
Bhatia S, Francisco L, Carter A, Sun C, Baker K, Gurney J . Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood. 2007; 110(10):3784-92. PMC: 2077324. DOI: 10.1182/blood-2007-03-082933. View